vs

Side-by-side financial comparison of Information Services Group Inc. (III) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Information Services Group Inc. is the larger business by last-quarter revenue ($61.2M vs $37.2M, roughly 1.6× Organogenesis Holdings Inc.). On growth, Information Services Group Inc. posted the faster year-over-year revenue change (2.7% vs -57.1%). Over the past eight quarters, Information Services Group Inc.'s revenue compounded faster (-2.4% CAGR vs -46.5%).

EBSCO Information Services, headquartered in Ipswich, Massachusetts, is a division of EBSCO Industries Inc., a private company headquartered in Birmingham, Alabama. EBSCO provides products and services to libraries of many types around the world. Its products include EBSCONET, a complete e-resource management system, and EBSCOhost, which supplies a fee-based online research service with 375 full-text databases, a collection of 600,000-plus ebooks, subject indexes, point-of-care medical refere...

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

III vs ORGO — Head-to-Head

Bigger by revenue
III
III
1.6× larger
III
$61.2M
$37.2M
ORGO
Growing faster (revenue YoY)
III
III
+59.7% gap
III
2.7%
-57.1%
ORGO
Faster 2-yr revenue CAGR
III
III
Annualised
III
-2.4%
-46.5%
ORGO

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
III
III
ORGO
ORGO
Revenue
$61.2M
$37.2M
Net Profit
$2.7M
Gross Margin
30.8%
Operating Margin
8.2%
-185.1%
Net Margin
4.4%
Revenue YoY
2.7%
-57.1%
Net Profit YoY
82.5%
EPS (diluted)
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
III
III
ORGO
ORGO
Q1 26
$61.2M
$37.2M
Q4 25
$61.2M
$225.6M
Q3 25
$62.4M
$150.9M
Q2 25
$61.6M
$101.0M
Q1 25
$59.6M
$86.7M
Q4 24
$57.8M
$126.7M
Q3 24
$61.3M
$115.2M
Q2 24
$64.3M
$130.2M
Net Profit
III
III
ORGO
ORGO
Q1 26
$2.7M
Q4 25
$2.6M
$43.7M
Q3 25
$3.1M
$21.6M
Q2 25
$2.2M
$-9.4M
Q1 25
$1.5M
$-18.8M
Q4 24
$3.0M
$7.7M
Q3 24
$1.1M
$12.3M
Q2 24
$2.0M
$-17.0M
Gross Margin
III
III
ORGO
ORGO
Q1 26
30.8%
Q4 25
44.8%
Q3 25
42.2%
Q2 25
42.2%
Q1 25
43.1%
72.6%
Q4 24
41.5%
75.5%
Q3 24
40.4%
76.7%
Q2 24
39.5%
77.6%
Operating Margin
III
III
ORGO
ORGO
Q1 26
8.2%
-185.1%
Q4 25
8.4%
28.1%
Q3 25
7.4%
13.7%
Q2 25
7.6%
-12.5%
Q1 25
5.7%
-30.9%
Q4 24
0.3%
8.1%
Q3 24
7.0%
5.4%
Q2 24
5.7%
-10.7%
Net Margin
III
III
ORGO
ORGO
Q1 26
4.4%
Q4 25
4.3%
19.4%
Q3 25
4.9%
14.3%
Q2 25
3.5%
-9.3%
Q1 25
2.5%
-21.7%
Q4 24
5.3%
6.1%
Q3 24
1.9%
10.7%
Q2 24
3.2%
-13.1%
EPS (diluted)
III
III
ORGO
ORGO
Q1 26
$0.05
Q4 25
$0.06
$0.31
Q3 25
$0.06
$0.11
Q2 25
$0.04
$-0.10
Q1 25
$0.03
$-0.17
Q4 24
$0.07
$0.05
Q3 24
$0.02
$0.09
Q2 24
$0.04
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
III
III
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$91.4M
Total DebtLower is stronger
Stockholders' EquityBook value
Total Assets
$520.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
III
III
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$28.7M
$93.7M
Q3 25
$28.7M
$63.7M
Q2 25
$25.2M
$73.1M
Q1 25
$20.1M
$110.0M
Q4 24
$23.1M
$135.6M
Q3 24
$9.7M
$94.3M
Q2 24
$11.8M
$89.9M
Total Debt
III
III
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
III
III
ORGO
ORGO
Q1 26
Q4 25
$94.7M
$300.1M
Q3 25
$94.7M
$255.1M
Q2 25
$94.1M
$233.2M
Q1 25
$95.0M
$242.9M
Q4 24
$96.3M
$262.9M
Q3 24
$96.6M
$278.5M
Q2 24
$95.5M
$263.5M
Total Assets
III
III
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$211.0M
$598.7M
Q3 25
$213.3M
$509.8M
Q2 25
$200.7M
$461.1M
Q1 25
$202.4M
$467.4M
Q4 24
$204.5M
$497.9M
Q3 24
$227.1M
$446.3M
Q2 24
$235.3M
$443.2M
Debt / Equity
III
III
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons